Skip to main content

Together we are beating cancer

Donate now

Cancer type

Showing 12 out of 2914 results

The increasing number of patients being discussed at expert cancer meetings means that specialists are under growing pressure. The increasing number of patients being discussed at expert cancer meetings means that specialists are under growing pressure.

by Cancer Research UK | News | 11 January 2017

11 January 2017

Targeting a molecule that helps cells repair their DNA could lead to a new treatment for some aggressive brain tumours, a University of Leeds study has found. Targeting a molecule that helps cells repair their DNA could lead to a new treatment for some aggressive brain tumours, a University of Leeds study has found.

by In collaboration with PA Media Group | News | 10 January 2017

10 January 2017

Scientists have uncovered how tumours are able to grow despite significant damage to the structure and number of their chromosomes - the storage units of DNA. Scientists have uncovered how tumours are able to grow despite significant damage to the structure and number of their chromosomes - the storage units of DNA.

by Cancer Research UK | News | 9 January 2017

9 January 2017

The two main types of oesophageal cancer display distinct genetic characteristics and should be studied separately in clinical trials, according to a new study. The two main types of oesophageal cancer display distinct genetic characteristics and should be studied separately in clinical trials, according to a new study.

by In collaboration with PA Media Group | News | 5 January 2017

5 January 2017

Our researchers may have found a new way to tap into the power of the immune system to fight cancer. Read about their work Our researchers may have found a new way to tap into the power of the immune system to fight cancer. Read about their work

by Justine Alford | Analysis | 3 January 2017

3 January 2017

NICE has published draft guidance stating that the breast cancer drug trastuzumab emtansine (also known as Kadcyla) won't be routinely available through the NHS NICE has published draft guidance stating that the breast cancer drug trastuzumab emtansine (also known as Kadcyla) won't be routinely available through the NHS

by Cancer Research UK | News | 29 December 2016

29 December 2016

A clinical trial of a type of laser treatment for prostate cancer hit the headlines. What do the results mean for patients? We spoke to an expert to find out. A clinical trial of a type of laser treatment for prostate cancer hit the headlines. What do the results mean for patients? We spoke to an expert to find out.

by Justine Alford | Analysis | 21 December 2016

21 December 2016

Our scientists are looking for ways to use blood tests in cancer prognosis and treatment planning. Our scientists are looking for ways to use blood tests in cancer prognosis and treatment planning.

by Michael Walsh | Analysis | 20 December 2016

20 December 2016